INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1999

Early reductions in muscle glucose-6-phosphate suggest free fatty acids primarily inhibit glucose transport/phosphorylation before whole-body uptake declines.

In seven healthy men, skeletal muscle metabolism was tracked via 31P nuclear magnetic resonance spectroscopy during euglycemic-hyperinsulinemic clamps under high, basal, and low free fatty acid (FFA) levels. Whole-body glucose uptake was approximately 20% lower after 140 minutes with basal and high FFAs (42.8 +/- 3.6 and 41.6 +/- 3.3 vs. control 52.7 +/- 3.3 micromol x kg(-1) x min(-1), P < 0.05). Intramuscular glucose-6-phosphate (G-6-P) was blunted at 45 minutes of high FFA exposure (184 +/- 17 vs. control: 238 +/- 17 micromol/l, P = 0.008) and remained lower at 180 minutes with high and basal FFAs versus control (P < 0.05). The authors conclude these early G-6-P patterns suggest FFAs primarily inhibit glucose transport/phosphorylation prior to reducing whole-body glucose disposal.

Study type
Euglycemic-hyperinsulinemic clamp trial
Who was studied
Seven healthy men
What was measured
Skeletal muscle glucose-6-phosphate, Pi, pH, and whole-body glucose uptake

THE PAPER

Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.

Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fürnsinn C, Moser E, Waldhäusl W. Diabetes, 1999.

PubMed 10334314 ↗DOI 10.2337/diabetes.48.2.358 ↗

Diabetes & blood sugarNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.